Mount Sinai and Stony Brook Announce Affiliation
Thursday, August 11, 2016
Posted by: Julie Briggs
We are pleased to announce that the Icahn School of Medicine at Mount Sinai and the Stony Brook School of Medicine have entered into an affiliation agreement that will transform clinical care and research, and enrich academic medicine programs at both institutions.
The partnership is intended to promote discovery, provide expanded clinical trials for both institutions, and advance the development of breakthroughs to understand and treat disease.
Mount Sinai and Stony Brook will collaborate to develop a wide range of research programs in fields including biomedical engineering and computer science; drug discovery and medicinal chemistry sciences; neuroscience, neurology, and psychiatry; basic biology and novel therapeutics, and public health and health systems. The alliance will capitalize on Mount Sinai’s strengths in biomedical and clinical research, and health policy and outcomes, and on Stony Book’s expertise in mathematics, high-performance computing, imaging, and the physical and chemical sciences.
In addition, Mount Sinai and Stony Brook will invest a combined $500,000 to launch competitive and unique pilot programs with the intent of receiving collaborative external funding. Projects will be determined and overseen by a committee composed of three representatives from each institution.
Through the partnership, the schools will develop joint graduate and medical educational programs in all areas, leveraging the strength of existing master’s and doctoral programs at each institution. Students will have the opportunity to take classes on both campuses, allowing them to learn new techniques and expand their learning capacity. Mount Sinai and Stony Brook will also build summer programs for undergraduate, graduate, and postgraduate students.
We look forward to further developing this exciting collaboration and finding new ways to advance academics and clinical care.
Read the full press release here.